Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer : a report from the Central Japan Lung Study Group, CJLSG 0503 trial

• USAMI Noriyasu

  Division of Thoracic Surgery, Nagoya University Graduate School of Medicine

• YOKOI Kohei

  Division of Thoracic Surgery, Nagoya University Graduate School of Medicine

• HASEGAWA Yoshinori

  Department of Respiratory Medicine, Nagoya University Graduate School of Medicine

• TANIGUCHI Hiroyuki

  Department of Respiratory Medicine and Allergy, Tosei General Hospital

• SHINDO Joe

  Department of Respiratory Medicine, Ogaki Municipal Hospital

• YAMAMOTO Masashi

  Department of Respiratory Medicine, Ekisaikai Hospital

• SUZUKI Ryujiro

  Department of Respiratory Medicine, Toyohashi Municipal Hospital

• IMAIZUMI Kazuyoshi

  Department of Respiratory Medicine, Nagoya University Graduate School of Medicine

• KONDO Masashi

  Department of Respiratory Medicine, Nagoya University Graduate School of Medicine

• SHIMOKATA Kaoru

  Department of Respiratory Medicine, Nagoya University Graduate School of Medicine

• Central Japan Lung Study Group

Journal

• International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology

  International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology 15 (6), 583-587, 2010-12-01

Keywords

• Non-small cell lung cancer
• Adjuvant chemotherapy
• Carboplatin
• Gemcitabine
• Phase II study

Details

• CRID: 1573105976092027008
• NII Article ID: 10027665356
• NII Book ID: AA11086579
• ISSN: 13419625
• Text Lang: en
• Data Source:
  • CiNii Articles